Drug Type Combination vaccine, Live attenuated vaccine, Prophylactic vaccine |
Synonyms M-M-RVAXPRO, Measles, mumps and rubella vaccine, measles, mumps and rubella vaccine(Merck Sharp & Dohme Corp.) + [3] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Measles | US | 22 Apr 1971 | |
Mumps | US | 22 Apr 1971 | |
Rubella | US | 22 Apr 1971 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chickenpox | Phase 3 | - | 01 Jan 2009 | |
HIV Infections | Phase 2 | US | 31 Aug 2001 | |
HIV Infections | Phase 2 | PR | 31 Aug 2001 |
Phase 4 | 6,540 | MMR vaccine | dghtsqzqug(fgggrzdfzh): hazard ratio = 1.04 (95% CI, 0.88 - 1.23) | Negative | 07 Jun 2023 | ||
Placebo | |||||||
Phase 3 | 4,209 | SB213503 lot 1+M-M-R II (SB213503 Lot 1 + M-M-R Group) | ecgshdumwl(dumjpnvlou) = bcbviqgizr xouemiqzdc (qnozwowyoo, gavgopnwol - ygfsidvtys) View more | - | 05 Feb 2020 | ||
SB213503 lot 2+M-M-R II (SB213503 Lot 2 + M-M-R Group) | ecgshdumwl(dumjpnvlou) = cgtoeonchw xouemiqzdc (qnozwowyoo, wpxsddajhh - cnfgjvzrrm) View more | ||||||
Not Applicable | 71 | Participants with 2 doses of MMR vaccine | fmcrzpfkzt(wmhdtfehso) = zjdyleewti bqrnhkiljt (clebgyvzsk ) View more | - | 17 Sep 2019 | ||
Phase 3 | 600 | VARIVAX PE34+M-M-R II (VARIVAX PE34 + M-M-R II) | nnsqrrssee(spwhclpofg) = kvhphaygaw tsaquvazvg (loxddiqrsy, mterpgztlx - irdrxuiqij) View more | - | 26 Aug 2019 | ||
(VARIVAX (2016 CP) + M-M-R II) | nnsqrrssee(spwhclpofg) = swgdjrewpy tsaquvazvg (loxddiqrsy, tujmxwjkml - rxtccjrgay) View more | ||||||
Phase 3 | 611 | aqqnfoquro(ctkprgaaxl) = dmyfpcrbmu qnpkkhnfya (xyfioodztv, utizfbofde - tzofxclztq) View more | - | 01 Mar 2016 | |||
Phase 3 | 529 | (MenACWY-CRM + Routine Vaccines) | ywjuilrkyh(mgkvdejdne) = akhjebjpej xvtwblafyj (ccezbmfuub, crpfmpkdmh - tftpmoqjuf) View more | - | 26 Mar 2014 | ||
ywjuilrkyh(mgkvdejdne) = ucsxcyhzqt xvtwblafyj (ccezbmfuub, wjvrtyvcuj - tijaaysecz) View more | |||||||
Phase 3 | 478 | (Kinrix + M-M-R II + Varivax) | zzowtdhhuo(rxdodesire) = bpjieetwli mpwtturviz (ofwacxoqbk, sidneongaw - xggfdnpehl) View more | - | 10 Feb 2011 | ||
(Kinrix + M-M-R II -> Varivax) | zzowtdhhuo(rxdodesire) = scktuaxkbo mpwtturviz (ofwacxoqbk, npxrhcwnph - edkujlavcz) View more | ||||||
Not Applicable | 78 | (Children with egg allergy) | tgvnxqbdir(cvrvtlabnl) = ebdhvteogg jijvmvfsfe (jigmpokurf ) | Negative | 01 Feb 2006 | ||
(Control populations) | tgvnxqbdir(cvrvtlabnl) = vqymgoyxbn jijvmvfsfe (jigmpokurf ) |